ACE2	Angiotensin II receptor
ALI	Acute lung injury
ARDS	Acute respiratory distress syndrome
BSAAs	Broad-spectrum antiviral agents
CCTI	Chest computer tomography image
CDC	Centers for Disease Control and Prevention
CDSCO	Central Drugs Standard Control Organization
COVID-19	Coronavirus Disease 2019
CPE	Cytopathic effects
CRS	Cytokine release syndrome
CS	“Cytokine storm”
CT	Computed tomography
CXI	Chest X-ray image
DABK	Bradykinin metabolite [des-Arg973] BK
DCGI	Drugs Controller General of India
EGCG	Epigallocatechin gallate
ECDC	European Centre for Disease Prevention
EMA	European Medicines Agency
EUA	Emergency Use Authorization
FBSED	Fourier-Bessel series expansion-based decomposition
FDA	Food and Drug Administration
GBS	Guillain-Barre syndrome
GCG	Gallocatechingallate
GISAID	Global Initiative on Sharing All Influenza Data
HDIVC	High-dose intravenous vitamin C
hERG	Human ether-ago-go-related gene
HRQoL	Health-related quality of life
HZ	Herpes zoster
IFNAR	Human interferon alpha-receptor
IFN	Interferon
IgY	Immunoglobulin Y
IL	Interleukin
IVM	Ivermectin
LQTS	Long QT syndrome
MDR	Multidrug resistance
MFDS	Ministry of Food and Drug Safety
MHLW	Ministry of Health, Labour, and Welfare
Mpro	Main protease
NLR	Neutrophil to lymphocyte ratio
NMPA	National Medical Products Administration
NRA	National Regulatory Agency
PARP1	Poly-ADP-ribose polymerase 1
PCS	Post-acute COVID-19 syndrome
PMDA	Pharmaceuticals and Medical Devices Agency
RBD	Receptor-binding domain
RdRp	RNA-dependent RNA polymerase
RT-PCR	Reverse transcriptase-polymerase chain reaction
SARS-CoV-2	Severe acute respiratory syndrome coronavirus 2
TGA	Therapeutic Goods Administration
TNF-α	Tumor necrosis factor-α
VEGF	Vascular endothelial growth factor
VOCs	Variants of concern
VOIs	Variants of interest
VST	Venous sinus thrombosis
VZV	Varicella zoster virus
WHO	World Health Organization